Teleflex (NYSE:TFX) Shares Gap Up on Analyst Upgrade

Teleflex Incorporated (NYSE:TFX) shares gapped up before the market opened on Friday after Raymond James Financial upgraded the stock from a market perform rating to an outperform rating. The stock had previously closed at $110.49, but opened at $114.54. Raymond James Financial now has a $128.00 price target on the stock. Teleflex shares last traded at $114.9940, with a volume of 229,944 shares trading hands.

Other analysts have also recently issued research reports about the stock. Needham & Company LLC lifted their price target on shares of Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Wells Fargo & Company raised their target price on shares of Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a research report on Friday, February 27th. Royal Bank Of Canada lifted their target price on shares of Teleflex from $115.00 to $125.00 and gave the company a “sector perform” rating in a research note on Friday, February 27th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Finally, Zacks Research downgraded shares of Teleflex from a “hold” rating to a “strong sell” rating in a research note on Monday, March 2nd. Three investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $139.00.

Teleflex News Roundup

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Irenic, a ~2% Teleflex shareholder, called for the Board to form a strategic-review sub‑committee with independent directors and to engage potential acquirers — a direct catalyst for takeover interest that can lift valuation expectations. Irenic Comments on Teleflex’s Announcement That It Is Open to Strategic Alternatives
• Positive Sentiment: Raymond James upgraded Teleflex from Market Perform to Outperform with a $128 price target, signaling analyst conviction that there’s upside from either operational improvement or strategic outcomes. Raymond James upgrade coverage
• Neutral Sentiment: Teleflex issued a formal statement reiterating its commitment to value‑maximizing strategies and said management met with Irenic on March 19 to understand their views — indicates engagement but not yet a formal review process. Teleflex Reiterates Commitment to Value‑Maximizing Strategies and Strong Execution
• Neutral Sentiment: Other shareholders and outlets are echoing calls for Teleflex to engage potential buyers, adding public pressure that could push the Board toward a more formal process. Teleflex shareholder urges company engage buyers
• Negative Sentiment: Teleflex pushed back, saying Irenic falsely claimed the company was not open to buyout offers — the public dispute raises governance/uncertainty risk and could deter some bidders or prolong a process. Teleflex says Irenic falsely claimed company was not open for buyout offers
• Negative Sentiment: Fundamentals remain a headwind: Teleflex reported a large recent earnings and revenue miss and guidance that reflects recovery needs — operational weakness could limit strategic options or depress standalone valuation until results improve.

Institutional Trading of Teleflex

A number of hedge funds and other institutional investors have recently modified their holdings of TFX. Russell Investments Group Ltd. grew its holdings in Teleflex by 23.6% in the second quarter. Russell Investments Group Ltd. now owns 83,388 shares of the medical technology company’s stock worth $9,870,000 after purchasing an additional 15,935 shares during the period. Capital International Investors purchased a new position in shares of Teleflex during the third quarter valued at approximately $44,851,000. Public Sector Pension Investment Board lifted its holdings in shares of Teleflex by 24.9% during the third quarter. Public Sector Pension Investment Board now owns 188,208 shares of the medical technology company’s stock valued at $23,029,000 after purchasing an additional 37,539 shares during the last quarter. Invenomic Capital Management LP boosted its position in shares of Teleflex by 35.6% in the 3rd quarter. Invenomic Capital Management LP now owns 385,672 shares of the medical technology company’s stock worth $47,191,000 after purchasing an additional 101,287 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its position in shares of Teleflex by 113.9% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 58,047 shares of the medical technology company’s stock worth $7,366,000 after purchasing an additional 30,912 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Price Performance

The company has a current ratio of 2.54, a quick ratio of 2.01 and a debt-to-equity ratio of 0.81. The company has a market cap of $5.14 billion, a PE ratio of -5.66, a P/E/G ratio of 0.72 and a beta of 0.87. The firm has a 50 day moving average of $109.07 and a two-hundred day moving average of $116.67.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The company had revenue of $569.00 million during the quarter, compared to the consensus estimate of $912.57 million. During the same period last year, the firm posted $3.89 earnings per share. The company’s revenue was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 6th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Friday, March 6th. Teleflex’s dividend payout ratio is -6.62%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.